Xi Liu
Fundador en BEIJING STRONG BIOTECHNOLOGIES,INC. .
Fortuna: 171 M $ al 30/04/2024
Cargos activos de Xi Liu
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Director/Miembro de la Junta | 29/03/2001 | - |
| Director Ejecutivo | 16/03/2011 | - | |
| Fundador | 29/03/2001 | - | |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Director/Miembro de la Junta | 30/09/2020 | - |
Historial de carrera de Xi Liu
Formación de Xi Liu.
| Harbin Engineering University | Graduate Degree |
| Institute of Automation Chinese Academy of Sciences | Doctorate Degree |
Estadísticas
Internacional
| China | 5 |
Operativa
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
- Bolsa de valores
- Insiders
- Xi Liu
- Experiencia